22579-30-2 Usage
Uses
Used in Organic Synthesis:
(2-bromoethyl)cycloheptane is used as a building block for the production of various other chemical compounds due to its unique structure and reactivity.
Used in Pharmaceutical Industry:
(2-bromoethyl)cycloheptane is used as a starting material for the synthesis of bioactive compounds, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
(2-bromoethyl)cycloheptane is used as a starting material for the synthesis of crop protection compounds, aiding in the development of effective and safe agrochemicals.
Used as a Solvent:
(2-bromoethyl)cycloheptane is used as a solvent in various chemical processes, facilitating reactions and improving the efficiency of chemical synthesis.
Safety Precautions:
It is important to handle (2-bromoethyl)cycloheptane with caution as it can be harmful if ingested, inhaled, or absorbed through the skin, and can also cause irritation to the eyes and respiratory tract.
Check Digit Verification of cas no
The CAS Registry Mumber 22579-30-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,5,7 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 22579-30:
(7*2)+(6*2)+(5*5)+(4*7)+(3*9)+(2*3)+(1*0)=112
112 % 10 = 2
So 22579-30-2 is a valid CAS Registry Number.
22579-30-2Relevant articles and documents
Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives
Yokohama,Miwa,Aibara,Fujiwara,Matsumoto,Nakayama,Iwamoto,Mori,Moroi,Tsukada,Isoda
, p. 2391 - 2398 (2007/10/02)
A series of 6-alkyl- or 6-(cycloalkylalkyl)-[1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyr imidin-9(3H)-ones 1b-o was synthesized from the corresponding 1,3,4-thiadiazol-5-amines 3b-o and the antiallergic activities of the products were evaluated. Among the compounds 6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]p yrimidin-9(3H)-one 1h, whose X-ray crystallographic stereostructure is shown, was found to be a promising new antiallergic agent, which has low toxicity and dual activity as a leukotriene D4 receptor antagonist and as an orally active mast cell stabilizer.
